SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as investors rally behind optimistic sentiment regarding global expansion and potential upcoming oncology breakthroughs, while social media buzz focuses on a significant short interest and frustration with regulatory scrutiny. The community is actively discussing rumors of imminent international deals and the potential for a major short squeeze.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is currently seeing explosive investor interest and a significant price gap following a strong earnings report that highlighted accelerating AI infrastructure demand and robust data center growth. The community is actively debating the stock's valuation, with many bullish investors cheering the company's competitive position while others express caution over the rapid, parabolic run-up and broader sector volatility.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is facing significant community frustration and selling pressure as investors rotate capital into other semiconductor stocks, despite the company's dominant AI market position. Traders are actively debating whether this stagnation is a result of market manipulation or a lack of near-term catalysts leading into the upcoming earnings report.

Digi Power X, Inc. is a block chain technology company, which engages in crypto currency mining. It focuses on validation through mining, hosting solutions, and blockchain software solutions. It operates through the following segments: Cryptocurrency Mining, Sales of Energy and Electricity, and Colocation Services. The company was founded on February 18, 2017, and is headquartered in Miami, FL.

Digi Power X Inc. - Ordinary Shares (Sub voting)

Digi Power X is trending following the announcement of a landmark 10-year colocation agreement with Cerebras Systems for an AI data center, with the community actively debating whether the company's valuation gap will close as infrastructure demand scales. Investors are heavily focused on the stock's potential for a long-term re-rating alongside the upcoming Cerebras IPO, while managing concerns over high short interest and potential share dilution.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is surging amid a broad rally in the semiconductor sector, fueled by intense investor demand for memory chips essential to AI infrastructure and data center growth. The community remains highly bullish, citing strong fundamentals, significant capacity constraints, and anticipation of a continued re-rating as the company expands its role in the AI supply chain.

Zcash is a privacy-focused cryptocurrency that uses trustless zero-knowledge proofs to enable fully encrypted transactions while maintaining blockchain transparency and security. It was the first cryptocurrency to implement zero-knowledge encryption for private peer-to-peer payments, addressing the fundamental privacy gap in traditional cryptocurrencies that expose transaction details publicly.   With a fixed supply of 21 million ZEC and a halving schedule similar to Bitcoin, Zcash allows users to prove transactions are valid without revealing sensitive information like wallet balances, transaction amounts, or participant identities, making it suitable for everyday payments, long-term savings, and cross-border money transfers where financial confidentiality matters.  The protocol operates on its own blockchain currently using Proof-of-Work consensus, though it's evolving toward Proof-of-Stake through the planned "Crosslink" upgrade to enhance security, scalability, and energy efficiency. Zcash employs trustless zero-knowledge proofs (Halo) within its Orchard shielded pool to verify transactions without revealing sender, receiver, or amount information.   Users can choose between transparent public transactions and shielded private transactions through Unified Addresses, which work with both types. The network is faster and cheaper than Bitcoin, with new blocks mined every 75 seconds and transaction fees typically just a fraction of a cent. Privacy adoption has surged in 2025, with over 30% of total ZEC supply now held in fully shielded pools.  Zcash was created by a group of scientists in 2013 who initially proposed Zerocoin as a privacy extension to Bitcoin before building a standalone protocol. The ecosystem operates with a self-funded development model where block rewards support independent teams through the Zcash Community Grants Committee and a new Coinholder-Controlled Fund.

Zcash

Zcash is trending as investors react to its potential as a quantum-resistant privacy asset, with the community closely tracking its performance relative to broader market shifts and anticipated regulatory developments. While some traders are aggressively building positions in anticipation of a privacy sector rotation, others remain cautious of the volatility and debating the long-term outlook for the coin versus Bitcoin.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is surging after delivering strong earnings and an improved margin outlook that overshadowed a revenue miss, fueling intense community discussion about a potential short squeeze. Investors are actively debating whether this performance marks a sustainable re-rating for the undervalued stock or if lingering concerns regarding the company's accounting reputation and ongoing legal developments will cap the momentum.

Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. It operates through the following segments: Personal Lending, Auto Lending, and Other. The Personal Lending segment focuses on unsecured personal loans and small dollar loans. The Auto Lending segment is involved in auto refinance and auto retail loans. The Other segment refers to HELOCs and other. The company was founded by David Joseph Girouard, Anna Mongayt Counselman, and Paul Gu in December 2013 and is headquartered in San Mateo, CA.

Upstart Holdings Inc

Upstart shares are seeing increased volatility and active community discussion following the announcement of a multi-year loan purchase agreement with Fortress Investment Group. Investors are debating the stock's high short interest and technical chart patterns, with many focusing on whether this partnership and recent sentiment shifts in the fintech sector can spark a sustained rally toward previous price levels.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing an explosive, parabolic rally driven by structural memory chip shortages and massive demand from AI data centers that analysts expect to persist for several years. The stock's rapid appreciation has sparked intense debate among the community, with many traders riding the momentum toward new highs while others express skepticism over the sustainability of such aggressive vertical moves.

Roundhill ETF Trust - Roundhill Memory ETF

The DRAM ETF is surging as investors target a memory supercycle fueled by an explosive, AI-driven demand for HBM and NAND flash storage that exceeds current supply. The community is heavily focused on this 'digital oil' narrative, viewing the ETF as a strategic way to capture exposure to key memory industry leaders like Micron, Samsung, and SK Hynix.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Organogenesis (ORGO) Projected to Post Earnings on Thursday

Organogenesis (NASDAQ:ORGO) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-organogenesis-holdings-inc-stock...

Organogenesis (NASDAQ:ORGO) Trading Up 1.7% - Time to Buy?

Organogenesis (NASDAQ:ORGO) Shares Up 1.7% - What's Next...

<ul class="summary-bullets"><li>ReNu is a cryopreserved, amniotic suspension allograft.</li><li>The company decided to initiate a rolling application for ReNu following the completion of a meeting with the FDA.</li><li>The treatment received FDA’s Regenerative Medicine Advanced Therapy (RMAT)-designation in 2021.</li></ul> Shares of Organogenesis Holdings Inc. (ORGO) jumped 22% in Monday’s extended trading hours after the company said that it met with the U.S. Food and Drug Administration (FDA), and now plans to initiate seeking approval for its experimental treatment ReNu before the end of December.The company is seeking approval for ReNu in the treatment of knee osteoarthritis pain, a degenerative joint disease that is estimated to affect nearly 31.1 million Americans.ReNu is a cryopreserved, amniotic suspension allograft. It provides anti-inflammatory, growth factor, and cellular components, offering a non-surgical alternative to reduce inflammation, alleviate pain, and enhance joint function. The treatment received FDA’s Regenerative Medicine Advanced Therapy (RMAT)-designation in 2021.<h2 class="st-heading-2">ReNu Application</h2>The company decided to initiate a rolling application for ReNu following the completion of a meeting with the FDA.“We are excited about the outcome of our FDA meeting and reaching this important milestone in the ReNu program. We are pleased the ReNu clinical development program consisting of two large Phase 3 randomized controlled trials (RCT), extensive commercial history and Regenerative Medicine Advanced Therapy (RMAT)-designation is appropriate for BLA submission,” said Patrick Bilbo, Chief Operating Officer of Organogenesis.<h2 class="st-heading-2">How Did Retail Traders React?</h2>On Stocktwits, retail sentiment around ORGO stock stayed within the ‘neutral’ territory while message volume remained at ‘normal’ levels.According to data from Koyfin, the sole analyst covering ORGO rated it ‘Buy’ with a $8 price target that implies a potential upside of about 257% from current trading levels.<a href="https://stocktwits.com/symbol/ORGO">ORGO stock</a> has fallen 42% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/neurocrine-soleno-deal-garners-wall-street-praise/cZJ4wmmRIYV">Neurocrine-Soleno Deal Garners Wall Street Praise — Analyst Applauds Business Development Acumen</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Global stock market chart and trading board - stock photo

ORGO Stock Rallies After Hours On Clearing Regulatory Pathway For Pain Relief Treatment 

Organogenesis is seeking approval for ReNu in knee osteoarthritis pain, a degenerative joint disease that is estimated to affect nearly 31.1 million Americans.

Equity

Organogenesis is seeking approval for ReNu in knee osteoarthritis pain, a degenerative joint disease that is estimated to affect nearly 31.1 million Americans.


Organogenesis (NASDAQ:ORGO) Receives "Buy" Rating from BTIG Research

BTIG Research reissued a "buy" rating and issued a $8.00 price objective on shares of Organogenesis in a research report on Thursday...

Assenagon Asset Management S.A. Acquires 680,392 Shares of Organogenesis $ORGO

Assenagon Asset Management S.A. raised its stake in shares of Organogenesis (NASDAQ:ORGO - Free Report) by 14.0% during the fourth quarter, according to its most recent disclosure with the Securities...

Organogenesis $ORGO Shares Acquired by First Light Asset Management LLC

First Light Asset Management LLC lifted its stake in shares of Organogenesis (NASDAQ:ORGO - Free Report) by 10.6% during the 3rd quarter, according to the company in its most recent filing with the...

Insider Buying: Organogenesis (NASDAQ:ORGO) Director Buys 5,000 Shares of Stock

Organogenesis (NASDAQ:ORGO - Get Free Report) Director Arthur Leibowitz purchased 5,000 shares of the stock in a transaction on Monday, March 9th. The stock was acquired at an average cost of $2.68...

Michael Joseph Driscoll Buys 10,000 Shares of Organogenesis (NASDAQ:ORGO) Stock

Organogenesis (NASDAQ:ORGO - Get Free Report) Director Michael Joseph Driscoll purchased 10,000 shares of the business's stock in a transaction on Monday, March 9th. The shares were purchased at an...

Insider Buying: Organogenesis (NASDAQ:ORGO) Director Buys $13,400.00 in Stock

Organogenesis (NASDAQ:ORGO - Get Free Report) Director Arthur Leibowitz acquired 5,000 shares of the firm's stock in a transaction on Monday, March 9th. The shares were acquired at an average price...

Organogenesis (NASDAQ:ORGO) Director Michael Joseph Driscoll Purchases 10,000 Shares of Stock

Organogenesis (NASDAQ:ORGO - Get Free Report) Director Michael Joseph Driscoll bought 10,000 shares of the firm's stock in a transaction dated Monday, March 9th. The stock was purchased at an average...

Organogenesis Holdings, Inc. is a regenerative medical company, which engages in the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.

Organogenesis Holdings Inc - Ordinary Shares - Class A

Still early innings

Overdone

Consolidation due before next leg up

Memory stocks have surged over the past year - is the run overdone or still early innings?

ORGO
Organogenesis Holdings Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Poll

Latest ORGO News

ORGOOrganogenesis Holdings Inc - Ordinary Shares - Class A